Interestingly, the levels of total circulating Tregs (expressed as a percentage of CD4+ T cells) did not differ between the two groups (Fig. 2f), indicating that the increase in the OX40+ subset in CRC patients was not due to elevated Treg levels in general. This evidence concerns the gene CD4 and colorectal carcinoma.